The Beauty Health Company (NASDAQ: SKIN) shares plummeted more than 50% in premarket trading after the company missed consensus third-quarter ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS View Analyst PT Change Downgrades Earnings Guidance Hot List

The Beauty Health Company (SKIN) PT Lowered to $5 at DA DavidsonNovember 14, 2023 8:12 AM The Beauty Health Company (SKIN) PT Lowered to $3 at StifelNovember 14, 2023 7:19 AM Raymond James Downgrades The Beauty Health Company (SKIN) to UnderperformNovember 14, 2023 7:04 AM Benchmark Downgrades The Beauty Health Company (SKIN) to HoldNovember 14, 2023 6:13 AM William Blair Downgrades The Beauty Health Company (SKIN) to Market PerformNovember 14, 2023 6:03 AM TD Cowen Downgrades The Beauty Health Company (SKIN) to Market PerformNovember 14, 2023 5:29 AM Piper Sandler Downgrades The Beauty Health Company (SKIN) to Underweight, 'Too Messy and Too Uncertain'November 14, 2023 2:27 AM JPMorgan Downgrades The Beauty Health Company (SKIN) to Underweight, 'hampered by execution challenges'November 14, 2023 2:23 AM Canaccord Downgrades The Beauty Health Company (SKIN) to Hold, 'lack of visibility of SKIN returning to growth plan'November 14, 2023 12:58 AM The Beauty Health Company (SKIN) Misses Q3 EPS by 63c; lowers guidanceNovember 13, 2023 4:13 PM The Beauty Health Company's (SKIN) President and CEO to DepartNovember 13, 2023 4:08 PM